Baker Bros. Advisors — CRNX

How Baker Bros. Advisors's position in CRINETICS PHARMACEUTICALS INC changed quarter by quarter. Change badges compare each quarter to the fund's immediately-prior filing.

Quarter	Shares	Value	% of portfolio	Change
Q1 2026	2,351,465	$85,405,209	0.49%	ADD
Q4 2025	1,648,869	$76,754,852	0.45%	NEW